Aug 11 (Reuters) - Histogen Inc HSTO.O :
* HISTOGEN REPORTS SECOND QUARTER 2021 EARNINGS AND PROVIDES
BUSINESS UPDATE
* HISTOGEN INC - POSITIVE TOP-LINE STUDY RESULTS FROM ITS
PHASE 1
STUDY OF EMRICASAN IN MILD SYMPTOMATIC COVID-19 PATIENTS
* HISTOGEN INC - HST 004 SELECTED AS PRODUCT CANDIDATE FOR
SPINAL
DISC REPAIR WITH IND ENABLING ACTIVITIES UNDERWAY
* HISTOGEN INC - INITIATED PHASE 1/2 STUDY OF HST 003 FOR
CARTILAGE REGENERATION IN KNEE
* HISTOGEN INC - QTRLY LOSS PER SHARE $0.10
Source text for Eikon: ID:nGNX4vMTKj
Further company coverage: HSTO.O
((Reuters.Briefs@thomsonreuters.com;))